Daniel R. Passeri
2023 - Cue Biopharma
In 2023, Daniel R. Passeri earned a total compensation of $3M as Chief Executive Officer at Cue Biopharma, a 119% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,407,500 |
|---|---|
| Salary | $604,824 |
| Other | $3,156 |
| Total | $3,015,480 |
Passeri received $2.4M in option awards, accounting for 80% of the total pay in 2023.
Passeri also received $604.8K in salary and $3.2K in other compensation.
Rankings
In 2023, Daniel R. Passeri's compensation ranked 302nd out of 2,978 executives tracked by ExecPay. In other words, Passeri earned more than 89.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 302 out of 2,978 | 90th |
Division Manufacturing | 166 out of 1,637 | 90th |
Major group Chemicals And Allied Products | 111 out of 906 | 88th |
Industry group Drugs | 108 out of 869 | 88th |
Industry Pharmaceutical Preparations | 67 out of 627 | 89th |
Source: SEC filing on April 26, 2024.
Passeri's colleagues
We found two more compensation records of executives who worked with Daniel R. Passeri at Cue Biopharma in 2023.